Biogen (BIIB) Tops Q1 EPS by 14c
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $200.05 +0.05%
EPS Growth %: -41.9%
Financial Fact:
Income tax expense: 337M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -41.9%
Financial Fact:
Income tax expense: 337M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $6.98, $0.14 better than the analyst estimate of $6.84. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.39 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Carvana (CVNA) PT Lowered to $85 at RBC Capital
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
